CITIGROUP INC - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 95 filers reported holding AKERO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,477,308
-31.0%
108,290
-36.3%
0.00%
-20.0%
Q2 2023$7,934,265
+55.3%
169,935
+27.3%
0.01%
+25.0%
Q1 2023$5,108,360
+12.2%
133,517
+60.7%
0.00%0.0%
Q4 2022$4,551,633
+5968.8%
83,059
+3677.1%
0.00%
Q3 2022$75,000
+92.3%
2,199
-46.1%
0.00%
Q2 2022$39,000
-78.6%
4,077
-68.2%
0.00%
Q1 2022$182,000
-82.7%
12,819
-74.3%
0.00%
-100.0%
Q4 2021$1,054,000
+50.8%
49,844
+59.3%
0.00%
Q3 2021$699,000
-62.9%
31,281
-58.8%
0.00%
-100.0%
Q2 2021$1,882,000
+7.9%
75,844
+26.1%
0.00%0.0%
Q1 2021$1,744,000
+1443.4%
60,127
+1277.5%
0.00%
Q4 2020$113,000
+11.9%
4,365
+32.8%
0.00%
Q3 2020$101,000
-47.7%
3,286
-57.5%
0.00%
Q2 2020$193,000
+94.9%
7,735
+65.2%
0.00%
Q1 2020$99,000
+39.4%
4,683
+46.9%
0.00%
Q4 2019$71,000
+1320.0%
3,187
+1410.4%
0.00%
Q3 2019$5,0002110.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 5,830,203$179,512,00024.20%
venBio Partners LLC 2,444,311$75,260,00011.44%
Versant Venture Management, LLC 777,727$23,946,0004.38%
Redmile Group, LLC 2,336,357$71,936,0001.32%
Vivo Capital, LLC 571,833$17,607,0001.02%
Cormorant Asset Management, LP 859,550$26,466,0001.02%
Boxer Capital, LLC 831,495$25,602,0000.88%
Integral Health Asset Management, LLC 85,000$2,617,0000.80%
EAM Global Investors LLC 49,718$1,531,0000.56%
Crawford Lake Capital Management, LLC 43,826$1,349,0000.56%
View complete list of AKERO THERAPEUTICS INC shareholders